- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07661550
Prevention of Postpartum Smoking Relapse and Related Health Consequences by Breastfeeding Promotion
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
We propose a randomized controlled trial to reduce postpartum smoking relapse by breastfeeding promotion from late pregnancy to 12 months postpartum. We will enroll 280 pregnant mothers who successfully quit smoking during this pregnancy (≤28 weeks). After the pre-test, participants who are still smoking abstinent will be randomized into either the breastfeeding intervention group (N=140) or the attention control group (N=140). The intervention group will receive a multicomponent intervention consisting of breastfeeding education, lactation counseling, social support, contingent financial incentives, and early limited formula milk via syringe feeding (optional for at-risk infants). The control group will receive counseling and support focusing on general infant care, with attention and monetary earnings similar to the intervention group. Both groups will receive usual care (i.e., information, education, and Quitline) for postpartum smoking relapse. The outcomes are postpartum smoking relapse, breastfeeding practices, and maternal and child health.
Aim 1 is to examine the efficacy of breastfeeding promotion intervention on postpartum smoking relapse. Aim 2 is to examine potential mediating mechanisms: reductions in stress and negative affect, enhancing mother-infant bonding and maternal sensitivity, and maternal weight retention. Aim 3 is to assess the effects of breastfeeding promotion intervention on maternal and infant health among ex-smoking mothers. This innovative study can yield promising data to support a new intervention to prevent postpartum smoking relapse. It has the potential to reduce smoking-related harms to both the mother and the infant, maximize the protective effects of breastfeeding on infant health and development, and narrow health disparities.
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Xiaozhong Wen
- Telefonnummer: 716-829-6811
- E-post: xiaozhon@buffalo.edu
Studieorter
-
-
New York
-
Buffalo, New York, Förenta staterna, 14214
- Rekrytering
- Division of Behavioral Medicine Department of Pediatrics Jacobs School of Medicine and Biomedical Sciences State University of New York at Buffalo
-
Kontakt:
- Xiaozhong Wen
- Telefonnummer: 716-829-6811
- E-post: xiaozhon@buffalo.edu
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Beskrivning
Inclusion Criteria:
- Be pregnant
- Be 18 years or older
- Have quit smoking cigarettes during this pregnancy
- Be willing to receive infant care and breastfeeding education
- Be able to read, listen, and talk in English
Exclusion Criteria:
- Medical conditions contraindicating breastfeeding, such as HIV infection, active tuberculosis, and breast removal
- Current heavy drinking (≥4 standard drinks on any day or ≥8 standard drinks per week)
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Placebo-jämförare: Uppmärksamhet placebo kontrollgrupp
Allmän rådgivning och stöd för spädbarnsvård
|
The control group will receive instructions on general pregnancy and infant care from this project
|
|
Experimentell: Breastfeeding intervention grou
A multicomponent behavioral intervention to promote breastfeeding
|
The intervention group will receive a multicomponent intervention promoting breastfeeding, including education, lactation counseling, social support, breastfeeding-contingent financial incentives, and early limited formula milk via syringe feeding (optional for at-risk infants).
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Number of participants reporting to smoke
Tidsram: 12 months postpartum
|
12 months postpartum
|
Sekundära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Number of participants reporting to breastfeed
Tidsram: 12months postpartum
|
12months postpartum
|
|
Systolic blood pressure level
Tidsram: 12 months postpartum
|
12 months postpartum
|
|
Diastolic blood pressure level
Tidsram: 12 months postpartum
|
12 months postpartum
|
|
Infant weight-for-length z-score
Tidsram: 12 months of age
|
12 months of age
|
|
Infant length-for-age z-score
Tidsram: 12 months of age
|
12 months of age
|
|
Infant head circumference
Tidsram: 12 months of age
|
12 months of age
|
|
Infant arm circumference
Tidsram: 12 months of age
|
12 months of age
|
|
Number of infants with bronchiolitis
Tidsram: 12 months of age
|
12 months of age
|
Samarbetspartners och utredare
Samarbetspartners
Utredare
- Huvudutredare: Xiaozhong Wen, State University of New York at Buffalo
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- STUDY00002632
- R01HD117113 (U.S.S. NIH-anslag/kontrakt)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .